These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 22876658)
1. [Validation of 2009 TNM classification based on a prognostic analysis of 350 patients treated for renal cell carcinoma]. Yasunaga Y; Komori K; Harada Y; Tohda A; Oka T Nihon Hinyokika Gakkai Zasshi; 2012 May; 103(3):540-7. PubMed ID: 22876658 [TBL] [Abstract][Full Text] [Related]
2. Reclassification of the current tumor, node, metastasis staging in pT3 renal cell carcinoma. Fujita T; Iwamura M; Yanagisawa N; Muramoto M; Okayasu I; Baba S Int J Urol; 2008 Jul; 15(7):582-6. PubMed ID: 18479355 [TBL] [Abstract][Full Text] [Related]
3. Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? Novara G; Ficarra V; Antonelli A; Artibani W; Bertini R; Carini M; Cosciani Cunico S; Imbimbo C; Longo N; Martignoni G; Martorana G; Minervini A; Mirone V; Montorsi F; Schiavina R; Simeone C; Serni S; Simonato A; Siracusano S; Volpe A; Carmignani G; Eur Urol; 2010 Oct; 58(4):588-95. PubMed ID: 20674150 [TBL] [Abstract][Full Text] [Related]
4. Tumor size and Fuhrman grade further enhance the prognostic impact of perinephric fat invasion and renal vein extension in T3a staging of renal cell carcinoma. Chen K; Lee BL; Huang HH; Tan BY; Lee LS; Ng LG; Lau W; Yuen JS Int J Urol; 2017 Jan; 24(1):51-58. PubMed ID: 27757999 [TBL] [Abstract][Full Text] [Related]
5. A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients. Ficarra V; Galfano A; Guillé F; Schips L; Tostain J; Mejean A; Lang H; Mulders P; De La Taille A; Chautard D; Descotes JL; Cindolo L; Novara G; Rioux-Leclercq N; Zattoni F; Artibani W; Patard JJ J Urol; 2007 Aug; 178(2):418-24; discussion 423-4. PubMed ID: 17561128 [TBL] [Abstract][Full Text] [Related]
6. Proposal for reclassification of the TNM staging system in patients with locally advanced (pT3-4) renal cell carcinoma according to the cancer-related outcome. Ficarra V; Novara G; Iafrate M; Cappellaro L; Bratti E; Zattoni F; Artibani W Eur Urol; 2007 Mar; 51(3):722-9; discussion 729-31. PubMed ID: 16904819 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors? Brookman-May SD; May M; Wolff I; Zigeuner R; Hutterer GC; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Feciche B; Figenshau RS; Madison K; Sánchez-Chapado M; Santiago Martin Mdel C; Salzano L; Lotrecchiano G; Zastrow S; Wirth M; Sountoulides P; Shariat S; Waidelich R; Stief C; Gunia S; ; Eur Urol; 2015 May; 67(5):943-51. PubMed ID: 25684695 [TBL] [Abstract][Full Text] [Related]
8. Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project). May M; Surcel C; Capitanio U; Dell'Oglio P; Klatte T; Shariat S; Ecke T; Wolff I; Vergho D; Wagener N; Huck N; Pahernik S; Zastrow S; Wirth M; Borgmann H; Haferkamp A; Musquera M; Krabbe LM; Herrmann E; Scavuzzo A; Mirvald C; Hutterer G; Zigeuner R; Stief CG; Waidelich R; Cindolo L; Kalusova K; Brookman-May SD; Scand J Urol; 2017 Aug; 51(4):269-276. PubMed ID: 28399699 [TBL] [Abstract][Full Text] [Related]
9. Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy. Thompson RH; Cheville JC; Lohse CM; Webster WS; Zincke H; Kwon ED; Frank I; Blute ML; Leibovich BC Cancer; 2005 Jul; 104(1):53-60. PubMed ID: 15895375 [TBL] [Abstract][Full Text] [Related]
10. [Survival analysis for localized renal cell carcinoma. Prognostic value of 1997 TNM classification]. García Torrelles M; Sánchez Sanchís M; Beltrán Armada JR; Bautista Rentero D; Vidal Moreno J; Sanjuán de Laorden C Actas Urol Esp; 2006; 30(7):655-60. PubMed ID: 17058609 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinoma. Pichler M; Hutterer GC; Chromecki TF; Jesche J; Kampel-Kettner K; Groselj-Strele A; Hoefler G; Pummer K; Zigeuner R Histopathology; 2013 Jan; 62(2):237-46. PubMed ID: 23020176 [TBL] [Abstract][Full Text] [Related]
13. Is there a need to further subclassify pT2 renal cell cancers as implemented by the revised 7th TNM version? Waalkes S; Becker F; Schrader AJ; Janssen M; Wegener G; Merseburger AS; Schrader M; Hofmann R; Stöckle M; Kuczyk MA Eur Urol; 2011 Feb; 59(2):258-63. PubMed ID: 21030143 [TBL] [Abstract][Full Text] [Related]
14. Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma. Brookman-May S; May M; Zigeuner R; Shariat SF; Scherr DS; Chromecki T; Moch H; Wild PJ; Mohamad-Al-Ali B; Cindolo L; Wieland WF; Schips L; De Cobelli O; Rocco B; Santoro L; De Nunzio C; Tubaro A; Coman I; Feciche B; Truss M; Dalpiaz O; Hohenfellner M; Gilfrich C; Wirth MP; Burger M; Pahernik S; J Urol; 2011 Dec; 186(6):2175-81. PubMed ID: 22014800 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the 1997 tumour, nodes and metastases classification of renal cell carcinoma: experience in 172 patients. Minervini R; Minervini A; Fontana N; Traversi C; Cristofani R BJU Int; 2000 Aug; 86(3):199-202. PubMed ID: 10930914 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951 [TBL] [Abstract][Full Text] [Related]
17. TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion. Han KR; Bui MH; Pantuck AJ; Freitas DG; Leibovich BC; Dorey FJ; Zisman A; Janzen NK; Mukouyama H; Figlin RA; Belldegrun AS J Urol; 2003 Mar; 169(3):899-903; discussion 903-4. PubMed ID: 12576809 [TBL] [Abstract][Full Text] [Related]
18. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. Frank I; Blute ML; Leibovich BC; Cheville JC; Lohse CM; Zincke H J Urol; 2005 Jun; 173(6):1889-92. PubMed ID: 15879769 [TBL] [Abstract][Full Text] [Related]
19. pT1 substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of malignant renal epithelial tumors. Salama ME; Guru K; Stricker H; Peterson E; Peabody J; Menon M; Amin MB; De Peralta-Venturina M J Urol; 2005 May; 173(5):1492-5. PubMed ID: 15821466 [TBL] [Abstract][Full Text] [Related]